Navigation Links
Boston Scientific Announces FDA Approval of New Family of Advanced Pacemakers
Date:5/8/2008

ure events or performance. These forward-looking statements include, among other things, statements regarding our product performance, regulatory approval of our products, new product launches, competitive offerings, our growth strategy, and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A- Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will file thereafter. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions, or circumstances on which those expectations may be based, or that may affect the likelihood that actual results will differ from t
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Boston Micromachines Multi-DM Named One of the Years Most Innovative Products
2. Boston University School of Medicine researcher recipient of Memory Ride Grant
3. Success of Shape-Up Somerville Childhood Obesity Intervention to be Presented at the Friedman School Symposium at Tufts, October 29-31, 2007 - Boston
4. AAHFNs 2008 Annual Meeting in Boston Will Be Raising the Bar in Heart Failure Care
5. Families Invited to Celebrate Shire Day at Boston Childrens Museum
6. Boston Scientific Announces New Initiatives to Increase Shareholder Value
7. Boston Scientific Announces Additions to Clinical Sciences Organization
8. Boston University School of Medicine physician receives award from AATOD
9. Boston Scientific Announces Verdict in Cordis Litigation
10. Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses
11. Boston Scientific and GE Healthcare Announce their First Patient Data Link to Electronic Medical Record
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 Sermo ( http://www.sermo.com ), the ... the results of a new Sermo Vitals Report ... The report examines physician dialog about diabetes ... analysis of a variety of topics, including the ... prefer, and candid/verbatim comments on issues related to ...
(Date:12/16/2009)... -- While many of the,pharma companies are ... new and inmarket drugs, MarketsandMarkets on the ... various players. These pharma,forecasting solutions are designed ... as phase,III. These have a substantial impact ... entry strategy, manufacturing planning, sales force,promotion, and ...
(Date:12/16/2009)... 11-month interval lessens complication risks , , TUESDAY, Dec. 15 (HealthDay ... had such a profound impact on your life that you ... A new study suggests that you might want to wait ... more than 11 months could be even better. , ... less than six months, the chances of the baby dying, ...
(Date:12/16/2009)... site visitors can earn a free 21-count one week trial bottle ... ... Orion, MI (PRWEB) December 16, 2009 -- ImmuneResponse247.com ... Trial Sample” of Immune Response 247™ 6 Mushroom Formula , ... Medicinals, Immune Response 247™ 6 Mushroom Formula is packaged in FDA ...
(Date:12/16/2009)... into reach for many Houstonians with the announcement by Hearing Haven, ... ... (PRWEB) December 16, 2009 -- The cost of hearing aids ... by Hearing Haven, LLC of a new subscription based hearing plan. ... want to improve communications and relationships with family and friends by ...
Breaking Medicine News(10 mins):Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:For Babies' Sake, Pregnancy Spacing Matters 2Health News:For Babies' Sake, Pregnancy Spacing Matters 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4Health News:Monthly Subscription Hearing Aid Plan Announced for Houston 2
... A research conducted by the University of Alberta has revealed ... men and women, while performing the same tasks. This goes ... women really do work differently. The volunteers for the study ... tasks, verbal tasks, and memory tasks, while the functional Magnetic ...
... to retrieve information from different areas of the brain. ... at Baylor college of Medicine (BCM) // , reports in the ... the tissue representing the formation of memory) in Drosophila is formed ... by the gene amnesiac but lasted for two hours, but in ...
... Toronto General Hospital Sleep Research laboratory have found that ... of developing heart attacks // . People with sleep ... sleeping disorder can reduce the risk of developing stroke. ... 30 and 60 and grouped based on their sleeping ...
... relationship tends to make a more person happy when ... a casual association, according to a new study.// The ... studied data which was inclusive telephonic interviews with 691 ... the well being of the people with measures of ...
... study states that people at high risk for liver injury ... liver disease significantly by drinking more than two cups of ... people who have liver problem due to heavy alcohol intake, ... the words of the researchers, Constance E. Ruhl, MD, PhD ...
... of scientists at the Columbia University have found out as ... to keeping it off. // The key to this is ... people to avoid putting on weight after having lost it. ... lost weight, ended up regaining weight, according to estimates, because ...
Other Medicine News:
(Date:12/15/2009)... Dec. 15 Sonic Innovations, Inc. (Sonic), ... and solutions, donated $10,000 to its local Feeding ... 14, 2009. ,, Sonic Innovations President Paul Wennerholm ... America member, the Utah Food Bank, at the ... also participated in an office food drive and ...
(Date:12/15/2009)... DAYTON, Ohio, Dec. 15 Robbins & Myers, ... it will release results for its fiscal 2010 first ... on Wednesday, January 6, 2010. A live ... at 2:30 p.m., ET. Peter C. Wallace, ... Vice President and Chief Financial Officer, will be discussing ...
(Date:12/15/2009)... Services, Inc. (NYSE: WST ) today announced ... the first-quarter 2010 cash dividend of $0.16 per share. ... to shareholders of record on January 20, 2010. ... global manufacturer of components and systems for injectable drug ... and disposable components used in syringe, IV and blood ...
Breaking Medicine Technology:Sonic Innovations, Inc. Donates $10,000 to Feeding America 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 1BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 2BioMed Realty Announces Results of Tender Offer for its Exchangeable Notes 15116 3Waters Ships First Units of SYNAPT G2 Mass Spectrometer 15114 1Waters Ships First Units of SYNAPT G2 Mass Spectrometer 15114 2FDA Launches Orphan Drug Workshop at KGI 6860 1FDA Launches Orphan Drug Workshop at KGI 6860 2
... File NDA in Second Quarter of 2008 -, ... WPI ), a leading specialty pharmaceutical,company, announced positive results ... (OTG) in patients with overactive bladder (OAB). The,study met ... episodes, and secondary endpoints of reduction in frequency,and increases ...
... Fovea Pharmaceuticals SA, which, last,December 2007, ... today announced that,its product, Recombinant human rod-derived ... Orphan Medicinal Product from the,European Commission, following ... the Evaluation of Medicinal Products (EMEA) Committee ...
Other Medicine Technology:Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 2Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 3Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 4Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder 5Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 2Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 3
The pediatric blanket provides full coverage for pediatric patient care. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also red...
The Pediatric ThermoWrap™ is designed to fit the proportions of your young patient and wraps around the entire body, without interfering with the sterilized area of operation....
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
The design of the large pediatric underbody blanket conveniently warms the large child or small adult patient while allowing full access for surgeons and staff....
Medicine Products: